Malignant Ovarian Neoplasm — Trials

Malignant Ovarian Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,087 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 685
Recruiting: 386
Ph III recruiting: 46
Growth YoY: +10.6%
Industry share: 36%
Top sponsor: National Cancer Institute (NCI)
Termination share: 32.8%
Trials / 1,000 deaths: 53.2 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (437)

clinicaltrialsPublishedShowing 201–250 of 399 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04815408	PD-1 Antibody Combined Neoadjuvant Chemotherapy for Ovarian Cancer	unknown	Phase 2	40	Second Affiliated Hospital, Zhejiang University, School of MedicineOTHER	1	Mar 25, 2021	clinicaltrials
NCT04812938	Exploiting Pathogenic Tp53 Mutation for Early Diagnosis of Ovarian Cancer by Mean of Papanicolau Test(PAPAudit)	unknown	—	190	Azienda Ospedaliera San Giovanni BattistaOTHER